Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Annals of Surgical Oncology
Erschienen in: Annals of Surgical Oncology 1/2021

30.10.2020 | Gynecologic Oncology

The Landmark Series: Minimally Invasive Surgery for Cervical Cancer

verfasst von: Derman Basaran, MD, Mario M. Leitao Jr., MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Cervical cancer incidence and mortality have declined in developed countries during the past few decades as a result of screening programs and vaccination. However, it remains a significant cause of cancer-related mortality in young women. Early-stage cervical cancer, defined as disease limited to the cervix, has traditionally been treated with abdominal radical hysterectomy via laparotomy. Although most early-stage cervical cancers can be cured with open radical hysterectomy, the morbidity associated with open radical hysterectomy is significant compared with simple extrafascial hysterectomy. Since the early 1990s, minimally invasive surgery has been explored for the treatment of this disease, with the goal of minimizing the morbidity associated with open surgery, as reported for endometrial cancer surgery. This report reviews the landmark studies describing and evaluating minimally invasive surgery in the treatment of patients with early-stage cervical cancer.
Literatur
1.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–1953.PubMed
2.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.PubMed
3.
Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, et al. Randomised study of radical surgery versus radiotherapy for stage Ib–IIa cervical cancer. Lancet. 1997;350:535–40.PubMed
4.
Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD. Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol. 2009;201:485e1–9.
5.
Adams E, Boulton MG, Horne A, Rose PW, Durrant L, Collingwood M, et al. The effects of pelvic radiotherapy on cancer survivors: Symptom profile, psychological morbidity and quality of life. Clin Oncol (R Coll Radiol). 2014;26:10–7.PubMed
6.
Dursun P, Gultekin M, Ayhan A. The history of radical hysterectomy. J Low Genit Tract Dis. 2011;15:235–45.PubMed
7.
Hoffman MS. Extent of radical hysterectomy: Evolving emphasis. Gynecol Oncol. 2004;94:1–9.PubMed
8.
Meigs JV. Radical hysterectomy with bilateral pelvic lymph node dissections: A report of 100 patients operated on five or more years ago. Am J Obstet Gynecol. 1951;62:854–70.PubMed
9.
Obermair A, Brennan D, Bristow R (2017) Management of surgical complications of gynecologic cancer treatment. In: Dennis Chi AB, Dizon DS, Yashar C (eds) Principles and practice of gynecologic oncology. Wolters Kluwer, Alphen aan den Rijn, pp 823–830.
10.
Cibula D, Abu-Rustum NR, Fischerova D, Pather S, Lavigne K, Slama J, et al. Surgical treatment of “intermediate risk” lymph node-negative cervical cancer patients without adjuvant radiotherapy: a retrospective cohort study and review of the literature. Gynecol Oncol. 2018;151:438–43.PubMedPubMedCentral
11.
Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005;23:7428–36.PubMed
12.
Basaran D, Dusek L, Majek O, Cibula D. Oncological outcomes of nerve-sparing radical hysterectomy for cervical cancer: A systematic review. Ann Surg Oncol. 2015;22:3033–40.PubMed
13.
Obermair A, Asher R, Pareja R, Frumovitz M, Lopez A, Moretti-Marques R, et al. Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: Results of a randomized controlled trial. Am J Obstet Gynecol. 2020;222:249e1–e10.
14.
Dargent DF. Laparoscopic surgery in gynecologic oncology: Some disputable applications and one fruitful indication. Gynecol Oncol. 2005;97:725–6.PubMed
15.
Nezhat CR, Burrell MO, Nezhat FR, Benigno BB, Welander CE. Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection. Am J Obstet Gynecol. 1992;166:864–5.PubMed
16.
Ting HC. Laparoscopic radical hysterectomy: A preliminary experience. J Am Assoc Gynecol Laparosc. 1994;1(4, Part 2):S36.PubMed
17.
Sedlacek TV, Campion MJ, Hutchins RA, Reich H. Laparoscopic radical hysterectomy: A preliminary report. J Am Assoc Gynecol Laparosc. 1994;1(4, Part 2):S32.PubMed
18.
Spirtos NM, Eisenkop SM, Schlaerth JB, Ballon SC. Laparoscopic radical hysterectomy (type III) with aortic and pelvic lymphadenectomy in patients with stage I cervical cancer: surgical morbidity and intermediate follow-up. Am J Obstet Gynecol. 2002;187:340–8.PubMed
19.
Benjamin I, Bararat RR, Curtin JP, Jones WB, Lewis JL, Hoskins WJ. Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related human immunodeficiency virus infection. Obstet Gynecol. 1994;84:974–8.PubMed
20.
Pomel C, Atallah D, Le Bouedec G, Rouzier R, Morice P, Castaigne D, et al. Laparoscopic radical hysterectomy for invasive cervical cancer: 8-year experience of a pilot study. Gynecol Oncol. 2003;91:534–9.PubMed
21.
Li G, Yan X, Shang H, Wang G, Chen L, Han Y. A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib–IIa cervical cancer. Gynecol Oncol. 2007;105:176–80.PubMed
22.
Malzoni M, Tinelli R, Cosentino F, Fusco A, Malzoni C. Total laparoscopic radical hysterectomy versus abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our experience. Ann Surg Oncol. 2009;16:1316–23.PubMed
23.
Abu-Rustum NR, Gemignani ML, Moore K, Sonoda Y, Venkatraman E, Brown C, et al. Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy. Gynecol Oncol. 2003;91:402–9.PubMed
24.
Gil-Moreno A, Díaz-Feijoo B, Roca I, Puig O, Pérez-Benavente MA, Aguilar I, et al. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol. 2005;96:187–93.PubMed
25.
Ramirez PT, Soliman PT, Schmeler KM, dos Reis R, Frumovitz M. Laparoscopic and robotic techniques for radical hysterectomy in patients with early-stage cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S21–4.PubMed
26.
Obermair A, Gebski V, Frumovitz M, Soliman PT, Schmeler KM, Levenback C, et al. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008;15:584–8.PubMed
27.
Sert BM, Abeler VM. Robotic-assisted laparoscopic radical hysterectomy (Piver type III) with pelvic node dissection: case report. Eur J Gynaecol Oncol. 2006;27:531–3.PubMed
28.
Fanning J, Fenton B, Purohit M. Robotic radical hysterectomy. Am J Obstet Gynecol. 2008;198:649e1–4.
29.
Lowe MP, Chamberlain DH, Kamelle SA, Johnson PR, Tillmanns TD. A multi-institutional experience with robotic-assisted radical hysterectomy for early-stage cervical cancer. Gynecol Oncol. 2009;113:191–4.PubMed
30.
Sert BM, Boggess JF, Ahmad S, Jackson AL, Stavitzski NM, Dahl AA, et al. Robot-assisted versus open radical hysterectomy: a multi-institutional experience for early-stage cervical cancer. Eur J Surg Oncol. 2016;42:513–22.PubMed
31.
Nam JH, Park JY, Kim DY, Kim JH, Kim YM, Kim YT. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol. 2012;23:903–11.PubMed
32.
Shah CA, Beck T, Liao JB, Giannakopoulos NV, Veljovich D, Paley P. Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer. J Gynecol Oncol. 2017;28:e82.PubMedPubMedCentral
33.
Shazly SA, Murad MH, Dowdy SC, Gostout BS, Famuyide AO. Robotic radical hysterectomy in early-stage cervical cancer: a systematic review and meta-analysis. Gynecol Oncol. 2015;138:457–71.PubMed
34.
Jin YM, Liu SS, Chen J, Chen YN, Ren CC. Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer. PLoS One. 2018;13:e0193033.PubMedPubMedCentral
35.
Cantrell LA, Mendivil A, Gehrig PA, Boggess JF. Survival outcomes for women undergoing type III robotic radical hysterectomy for cervical cancer: a 3-year experience. Gynecol Oncol. 2010;117:260–5.PubMed
36.
Ramirez PT, Adams S, Boggess JF, Burke WM, Frumovitz MM, Gardner GJ, et al. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology’s Clinical Practice Robotics Task Force. Gynecol Oncol. 2012;124:180–4.PubMed
37.
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, et al. Cervical cancer, version 2.2015. J Natl Compr Canc Netw. 2015;13:395–404; quiz 404.PubMed
38.
Melamed A, Ramirez PT. Changing treatment landscape for early cervical cancer: outcomes reported with minimally invasive surgery compared with an open approach. Curr Opin Obstet Gynecol. 2020;32:22–7.PubMed
39.
Melamed A, Margul DJ, Chen L, Keating NL, Del Carmen MG, Yang J, et al. Survival after minimally invasive radical hysterectomy for early-stage cervical cancer. N Engl J Med. 2018;379:1905–14.PubMedPubMedCentral
40.
Leitao MM Jr. The LACC trial: has minimally invasive surgery for early-stage cervical cancer been dealt a knockout punch? Int J Gynecol Cancer. 2018;28:1248–50.PubMed
41.
Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379:1895–904.PubMed
42.
Acuna SA, Dossa F, Baxter NN. Frequency of misinterpretation of inconclusive noninferiority trials: the case of the laparoscopic vs open resection for rectal cancer trials. JAMA Surg. 2019;154:90–2.PubMed
43.
Uppal S, Gehrig PA, Peng K, Bixel KL, Matsuo K, Vetter MH, et al. Recurrence rates in patients with cervical cancer treated with abdominal versus minimally invasive radical hysterectomy: a multi-institutional retrospective review study. J Clin Oncol. 2020;38:1030–40.PubMed
44.
Cusimano MC, Baxter NN, Gien LT, Moineddin R, Liu N, Dossa F, et al. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2019;221:619 e1–e24.
45.
Paik ES, Lim MC, Kim MH, Kim YH, Song ES, Seong SJ, et al. Comparison of laparoscopic and abdominal radical hysterectomy in early-stage cervical cancer patients without adjuvant treatment: ancillary analysis of a Korean Gynecologic Oncology Group study (KGOG 1028). Gynecol Oncol. 2019;154:547–53.PubMed
46.
Kim SI, Lee M, Lee S, Suh DH, Kim HS, Kim K, et al. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: a matching study of two institutional hospitals in Korea. Gynecol Oncol. 2019;155:75–82.PubMed
47.
Chen X, Zhao N, Ye P, Chen J, Nan X, Zhao H, et al. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤ 2 cm. Int J Gynecol Cancer. 2020;30(5):564–71.PubMed
48.
Anchora LP, Turco LC, Bizzarri N, Capozzi VA, Lombisani A, Chiantera V, et al. How to select early-stage cervical cancer patients still suitable for laparoscopic radical hysterectomy: a propensity-matched study. Ann Surg Oncol. 2020;27:1947–55.
49.
Frumovitz M, Obermair A, Coleman RL, Pareja R, Lopez A, Ribero R, et al. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020;21:851–60.PubMed
50.
Charo LM, Vaida F, Eskander RN, Binder P, Saenz C, McHale M, et al. Rapid dissemination of practice-changing information: a longitudinal analysis of real-world rates of minimally invasive radical hysterectomy before and after presentation of the LACC trial. Gynecol Oncol. 2020;157:494–9.PubMed
51.
Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Cervical cancer, version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17:64–84.PubMed
52.
FIGO Gynecologic Oncology Committee. FIGO statement on minimally invasive surgery in cervical cancer. Int J Gynaecol Obstet. 2020;149:264.
53.
Querleu D, Cibula D, Concin N, Fagotti A, Ferrero A, Fotopoulou C, et al. Laparoscopic radical hysterectomy: a European Society of Gynaecological Oncology (ESGO) statement. Int J Gynecol Cancer. 2020;30:15.PubMed
54.
55.
Tewari KS. Minimally invasive surgery for early-stage cervical carcinoma: interpreting the laparoscopic approach to cervical cancer trial results. J Clin Oncol. 2019;37:3075–80.PubMed
56.
Koninckx PR, Puga M, Ussia A, Zupi E, Keckstein J, Adamian L, et al. Regarding: “the LACC trial and minimally invasive surgery in cervical cancer.” J Minim Invasive Gynecol. 2020;27:239–40.PubMed
57.
Kimmig R, Ind T. Minimally invasive surgery for cervical cancer: consequences for treatment after LACC Study. J Gynecol Oncol. 2018;29:e75.PubMedPubMedCentral
58.
Jensen PT, Schnack TH, Frøding LP, Bjørn SF, Lajer H, Markauskas A, et al. Survival after a nationwide adoption of robotic minimally invasive surgery for early-stage cervical cancer: a population-based study. Eur J Cancer. 2020;128:47–56.PubMed
59.
Brandt B, Sioulas V, Basaran D, Kuhn T, LaVigne K, Gardner GJ, et al. Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: survival outcomes. Gynecol Oncol. 2020;156:591–7.PubMedPubMedCentral
60.
Kohler C, Hertel H, Herrmann J, Marnitz S, Mallmann P, Favero G, et al. Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff: a multicenter analysis. Int J Gynecol Cancer. 2019;29:845–50.PubMed
61.
Boyraz G, Karalok A, Basaran D, Turan T. Vaginal closure with EndoGIA to prevent tumor spillage in laparoscopic radical hysterectomy for cervical cancer. J Minim Invasive Gynecol. 2019;26:602.PubMed
62.
63.
Chao X, Li L, Wu M, Ma S, Tan X, Zhong S, et al. Efficacy of different surgical approaches in the clinical and survival outcomes of patients with early-stage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China. BMJ Open. 2019;9:e029055.PubMedPubMedCentral
64.
Falconer H, Palsdottir K, Stalberg K, Dahm-Kähler P, Ottander U, Lundin ES, et al. Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial. Int J Gynecol Cancer. 2019;29:1072–6.PubMed
Metadaten
Titel
The Landmark Series: Minimally Invasive Surgery for Cervical Cancer
verfasst von
Derman Basaran, MD
Mario M. Leitao Jr., MD
Publikationsdatum
30.10.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2021
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-09265-0

Weitere Artikel der Ausgabe 1/2021

Annals of Surgical Oncology 1/2021 Zur Ausgabe

Hepatobiliary Tumors

Significance of Frailty in Prognosis After Hepatectomy for Elderly Patients with Hepatocellular Carcinoma

Thoracic Oncology

Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma

Gynecologic Oncology

Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group

Breast Oncology

Breast-Conserving Surgery is Oncologically Safe for Well-Selected, Centrally Located Breast Cancer

ASO Visual Abstract

Defining and Predicting Early Recurrence After Resection for Gallbladder Cancer

Peritoneal Surface Malignancy

Hepatobiliary Disease Resection in Patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | HNO-Chirurgie | Nachrichten

HNO-Op. auch mit über 90?

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.